| Original language | English (US) |
|---|---|
| Pages (from-to) | 1482-1484 |
| Number of pages | 3 |
| Journal | Journal of the American Academy of Child and Adolescent Psychiatry |
| Volume | 61 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2022 |
All Science Journal Classification (ASJC) codes
- Developmental and Educational Psychology
- Psychiatry and Mental health
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 61, No. 12, 12.2022, p. 1482-1484.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Hats Off
T2 - Journal Awards 2022
AU - Novins, Douglas K.
AU - Ng, Warren Y.K.
AU - Luby, Joan L.
AU - Brent, David A.
AU - Waxmonsky, James G.
N1 - Funding Information: Disclosure: Dr. Novins has received grant or research support from the National Institutes of Health and the Administration for Children and Families. Dr. Ng has reported the following leadership roles: Cicatelli and Associates Board Member, New York Council on Child and Adolescent Psychiatry Board Member, New York State Behavioral Health Services Advisory Council Member, and Global Health Justice Partnership–Youth Equity Science Project Advisory Board Member. Dr. Brent has received research support from the National Institute of Mental Health (NIMH), the American Foundation for Suicide Prevention (ASFP), the Once Upon a Time Foundation, and the Beckwith Foundation. He has received royalties from Guilford Press, from the electronic self-rated version of the C-SSRS from eRT, Inc., and from performing duties as an UpToDate Psychiatry Section Editor. He has received consulting fees from Healthwise, honoraria from the Klingenstein Third Generation Foundation for scientific board membership and grant reviews, and is a scientific board member for AFSP. He has received funding from NIMH, which supported the development of intellectual property for BRITE, the As Safe As Possible intervention, the Computerized Adaptive Screen for Suicidal Youth (CASSY) measure, a suicide risk machine learning algorithm, and the Screening Wizard screening tool. Dr. Waxmonsky has received grant or research support from Supernus Pharmaceuticals. He has served as a consultant to Ironshore and Adlon Therapeutics (provided statistical support for paper he coauthored). Dr. Luby has reported no biomedical financial interests or potential conflicts of interest. Funding Information: Disclosure: Dr. Novins has received grant or research support from the National Institutes of Health and the Administration for Children and Families. Dr. Ng has reported the following leadership roles: Cicatelli and Associates Board Member, New York Council on Child and Adolescent Psychiatry Board Member, New York State Behavioral Health Services Advisory Council Member, and Global Health Justice Partnership–Youth Equity Science Project Advisory Board Member. Dr. Brent has received research support from the National Institute of Mental Health (NIMH), the American Foundation for Suicide Prevention (ASFP), the Once Upon a Time Foundation, and the Beckwith Foundation. He has received royalties from Guilford Press, from the electronic self-rated version of the C-SSRS from eRT, Inc., and from performing duties as an UpToDate Psychiatry Section Editor. He has received consulting fees from Healthwise, honoraria from the Klingenstein Third Generation Foundation for scientific board membership and grant reviews, and is a scientific board member for AFSP. He has received funding from NIMH, which supported the development of intellectual property for BRITE, the As Safe As Possible intervention, the Computerized Adaptive Screen for Suicidal Youth (CASSY) measure, a suicide risk machine learning algorithm, and the Screening Wizard screening tool. Dr. Waxmonsky has received grant or research support from Supernus Pharmaceuticals. He has served as a consultant to Ironshore and Adlon Therapeutics (provided statistical support for paper he coauthored). Dr. Luby has reported no biomedical financial interests or potential conflicts of interest.
PY - 2022/12
Y1 - 2022/12
UR - http://www.scopus.com/inward/record.url?scp=85140486149&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140486149&partnerID=8YFLogxK
U2 - 10.1016/j.jaac.2022.09.429
DO - 10.1016/j.jaac.2022.09.429
M3 - Article
C2 - 36456060
AN - SCOPUS:85140486149
SN - 0890-8567
VL - 61
SP - 1482
EP - 1484
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
IS - 12
ER -